search
Back to results

The EMBER Trial for Weight Management Engagement

Primary Purpose

Obesity

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
EMBER
Control
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Obesity focused on measuring obesity, weight loss, treatment engagement

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Veteran using primary care at VA Palo Alto or Houston in prior year
  • BMI greater than or equal to 30 kg/m2

Exclusion Criteria:

  • Age 80 or older
  • Documentation of a suicide attempt in the past 30 days
  • Hospitalization in the past 30 days
  • Documentation or other evidence of cognitive impairment
  • VA weight management program use in past 2 years
  • Self-report from potential participant that they will not be in town for the majority of the 2 months following baseline
  • Self-report from potential participant they plan to leave VA Palo Alto or Houston within the next 6 months
  • Under age 18

Sites / Locations

  • VA Palo Alto Health Care System, Palo Alto, CARecruiting
  • Michael E. DeBakey VA Medical Center, Houston, TXRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

EMBER

Control

Arm Description

Self-help tool to increase weight management engagement

List of treatments

Outcomes

Primary Outcome Measures

Weight management use
Dichotomous variable representing whether participant has 1+ VA weight management visits in the 2 months after baseline, per administrative data and/or self-report of use of VA weight management programs via single item question.

Secondary Outcome Measures

Weight management use
Dichotomous variable representing whether participant has 1+ VA weight management visits in the 6 months after baseline, per administrative data and/or self-report of use of VA weight management programs via single item question.
Number of weight management visits
Number of weight management program visits per administrative data.
New weight management behavior
Count of new weight management behaviors since baseline visit via self-report to question based on NHANES item assessing whether participant tried to lose weight and how. Lowest possible value 0 new weight management behaviors, no upper limit. Any change is considered meaningful.
Quality of life
Self-report of quality of life as assessed with the VR12 physical and mental health composite scores (Boston University School of Public Health). Scores are standardized T-scores with mean = 50 and a standard deviation of 10. For individuals on the physical health score, a 6.5 unit change is considering clinically meaningful. For individuals on the mental health score, a 7.9 unit change is considering clinically meaningful. At the population level, a 1 unit change is considered clinically meaningful.
Weight Loss
Based on difference between self-reported weight at baseline and 6-months, supplemented with medical record data when possible.
Physical Activity
Measured with L-Cat (Kiernen et al, 2013), which is a 6-level categorical measure. An increase of one category is a clinically meaningful difference.

Full Information

First Posted
June 10, 2022
Last Updated
February 23, 2023
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT05424081
Brief Title
The EMBER Trial for Weight Management Engagement
Official Title
The EMBER Trial for Weight Management Engagement
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 19, 2022 (Actual)
Primary Completion Date
January 31, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will test whether EMBER, a self-help tool to increase weight loss treatment engagement, helps veterans engage in Veterans Health Administration (VHA) weight management programs. Participants will be randomly assigned to receive EMBER or a list of weight management programs (the control group). They will answer questions about health beliefs and behaviors and share information from their medical record at the start of the study, 2-months after the start of the study, and 6-months after the start of the study. Participants will receive compensation for each of these contacts. Participants will also receive a reminder call 10 days after they enroll in the study. All study contacts will be over the phone. The main hypothesis is that people who receive EMBER will be more likely to use VHA weight management programs than people in the control group.
Detailed Description
Background Almost 40% of veterans using the Veterans Health Administration (VHA) have obesity. However, few patients use VHA's effective weight management programs. This study tests the effectiveness of EMBER, a self-directed tool with the goal of Enhancing Motivation for Better Engagement and Reach (EMBER) for weight management. It is available in paper and digital formats. EMBER is not a weight management program, instead it engages veterans in existing programs by informing and guiding choices about weight management. Specific Aims Assess whether veterans randomized to EMBER are more likely to have any weight management engagement at 2-month follow-up (per electronic medical record data supplemented with self-report) compared to those randomized to the control arm (information sheet listing available programs). (Primary Outcome) Assess whether veterans randomized to EMBER have greater weight management program retention, weight management behaviors (e.g., physical activity), weight loss, and quality of life gains at 6-month follow-up compared to those randomized to the control arm. (Secondary Outcomes) Assess factors likely to affect EMBER's implementation. Preliminary implementation outcomes will be assessed via RE-AIM (Reach, Effectiveness, Implementation) and the Proctor et al. implementation outcomes framework (Acceptability, Appropriateness, Costs, Fidelity). (Implementation Outcomes) Methodology Randomized two site Hybrid Type 1 Effectiveness-Implementation Trial among veteran primary care patients with obesity in VA. Participants (N=470) will be randomized to EMBER or a control condition consisting of a list of available weight management programs. Logistic regressions will be used to assess Aims 1 and 2. Aim 3 results are descriptive.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obesity, weight loss, treatment engagement

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Participant outcomes will be assessed by an outside company with no knowledge of randomization status.
Allocation
Randomized
Enrollment
470 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
EMBER
Arm Type
Experimental
Arm Description
Self-help tool to increase weight management engagement
Arm Title
Control
Arm Type
Active Comparator
Arm Description
List of treatments
Intervention Type
Behavioral
Intervention Name(s)
EMBER
Intervention Description
Self-help tool to increase weight management engagement
Intervention Type
Behavioral
Intervention Name(s)
Control
Intervention Description
List of weight management programs
Primary Outcome Measure Information:
Title
Weight management use
Description
Dichotomous variable representing whether participant has 1+ VA weight management visits in the 2 months after baseline, per administrative data and/or self-report of use of VA weight management programs via single item question.
Time Frame
2-months post randomization
Secondary Outcome Measure Information:
Title
Weight management use
Description
Dichotomous variable representing whether participant has 1+ VA weight management visits in the 6 months after baseline, per administrative data and/or self-report of use of VA weight management programs via single item question.
Time Frame
6-months post randomization
Title
Number of weight management visits
Description
Number of weight management program visits per administrative data.
Time Frame
6-months post-randomization
Title
New weight management behavior
Description
Count of new weight management behaviors since baseline visit via self-report to question based on NHANES item assessing whether participant tried to lose weight and how. Lowest possible value 0 new weight management behaviors, no upper limit. Any change is considered meaningful.
Time Frame
2- and 6-months post randomization
Title
Quality of life
Description
Self-report of quality of life as assessed with the VR12 physical and mental health composite scores (Boston University School of Public Health). Scores are standardized T-scores with mean = 50 and a standard deviation of 10. For individuals on the physical health score, a 6.5 unit change is considering clinically meaningful. For individuals on the mental health score, a 7.9 unit change is considering clinically meaningful. At the population level, a 1 unit change is considered clinically meaningful.
Time Frame
2- and 6-months post randomization
Title
Weight Loss
Description
Based on difference between self-reported weight at baseline and 6-months, supplemented with medical record data when possible.
Time Frame
6-months post randomization
Title
Physical Activity
Description
Measured with L-Cat (Kiernen et al, 2013), which is a 6-level categorical measure. An increase of one category is a clinically meaningful difference.
Time Frame
2- and 6-months post randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Veteran using primary care at VA Palo Alto or Houston in prior year BMI greater than or equal to 30 kg/m2 Exclusion Criteria: Age 80 or older Documentation of a suicide attempt in the past 30 days Hospitalization in the past 30 days Documentation or other evidence of cognitive impairment VA weight management program use in past 2 years Self-report from potential participant that they will not be in town for the majority of the 2 months following baseline Self-report from potential participant they plan to leave VA Palo Alto or Houston within the next 6 months Under age 18
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Y Breland, PhD MS BA
Phone
(650) 493-5000
Ext
22105
Email
Jessica.Breland@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Marnelle Cruz, BA
Phone
(650) 493-5000
Email
marnelle.cruz@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jessica Yelena Breland, PhD MS BA
Organizational Affiliation
VA Palo Alto Health Care System, Palo Alto, CA
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Palo Alto Health Care System, Palo Alto, CA
City
Palo Alto
State/Province
California
ZIP/Postal Code
94304-1207
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Y Breland, PhD MS BA
Phone
(650) 493-5000
Ext
22105
Email
Jessica.Breland@va.gov
First Name & Middle Initial & Last Name & Degree
Jessica Yelena Breland, PhD MS BA
Facility Name
Michael E. DeBakey VA Medical Center, Houston, TX
City
Houston
State/Province
Texas
ZIP/Postal Code
77030-4211
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Terri Fletcher, PhD
Email
terri.fletcher@va.gov

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
A de-identified, anonymized dataset will be created and shared with qualified investigators.
IPD Sharing Time Frame
Datasets will be available within 1 year of publication.
IPD Sharing Access Criteria
Datasets meeting VA standards for disclosure to the public will be made available within 1 year of publication. Prior to distribution, a local privacy officer will certify that all datasets contains no PHI. Final data sets will be maintained locally until enterprise-level resources become available for long-term storage and access. Guidance on request and distribution processes will be provided by VA Office of Research & Development (ORD). Those requesting data will be asked to sign a Letter of Agreement.

Learn more about this trial

The EMBER Trial for Weight Management Engagement

We'll reach out to this number within 24 hrs